Bottom line
Is MECVX a good fund? The bottom line
MECVX is the Investor Class share class of NYLI Epoch Capital Growth Fund, a managed large growth mutual fund from New York Life Investments.
It charges 1.42% — about $142 a year on every $10,000 invested, more expensive than 86% of large growth funds we track.
It returned +7.4% over one year, +9.0% a year over five years (as of Dec 31, 2025, per its prospectus).
With $134 million in net assets and 115 holdings, its largest position is NVIDIA Corp. (3.9%) and the top 10 make up 20.7% of the portfolio.
This share class carries a front-end sales charge of up to 5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.42%)
- Front-end sales load up to 5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MECVX invests in
The Fund seeks long-term capital appreciation.
"The Fund generally invests in a diversified portfolio consisting of equity securities of companies located throughout the world, including the United States, that have a history of earning a high return on their invested capital relative to their cost of capital and that have positive growth in operating cash flow. Under normal circumstances, the Fund invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of companies across all market capitalizations. Equity securities include, among others, common stocks, depositary receipts, master limited partnerships, real estate investment trusts, warrants, and rights. The Fund may invest up to 20% of its net assets in securities issued by companies in emerging markets as determined by the Fund's Subadvisor, Epoch Investment Partners, Inc., when it believes those securities represent…
From the fund's prospectus (filed Feb 26, 2026).
MECVX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MECVX | +7.4% | +9.0% | — |
| Large Growth median | +15.2% | +11.0% | +14.2% |
Source: Fund prospectus, as of Dec 31, 2025
What MECVX costs
On a $10,000 investment, MECVX's 1.42% expense ratio costs about $142 a year. The prospectus estimates $2,117 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.
MECVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | NVIDIA Corp. | 3.91% |
| 2 | Apple, Inc. | 2.53% |
| 3 | Taiwan Semiconductor Manufacturing Co. Ltd. | 2.07% |
| 4 | Monster Beverage Corp. | 1.86% |
| 5 | Alphabet, Inc. | 1.77% |
| 6 | West Pharmaceutical Services, Inc. | 1.76% |
| 7 | Applied Materials, Inc. | 1.76% |
| 8 | Broadcom, Inc. | 1.72% |
| 9 | EMCOR Group, Inc. | 1.69% |
| 10 | Medpace Holdings, Inc. | 1.65% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 20.7% of the fund. See all top 25 holdings and asset mix →